(Reuters) -Novo Holdings, which controls obesity drugmaker Novo Nordisk, will sell 155 million shares, or about 7.8% of its stake, in British medical products maker Convatec Group, a bookrunner for the offering said on Monday.
(Reporting by Shashwat Awasthi in Bengaluru; Editing by Shilpi Majumdar)
Brought to you by www.srnnews.com